Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)

NCT03041662 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT03041662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03041662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
November 30, 2020
Enrollment
620 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, primary sclerosing cholangitis